The Australian Immunisation Handbook 10th Edition

Appendix 6: Commonly used abbreviations

Page last updated: 06 March 2017

PDF printable version of Appendix 6: Commonly used abbreviations of the 10th edition of the Handbook (PDF 44 KB)

  • ABLV Australian bat lyssavirus
  • ACIR Australian Childhood Immunisation Register
  • ACT Australian Capital Territory
  • ADRS Adverse Drug Reactions System
  • AEFI adverse event following immunisation
  • AIDS acquired immunodeficiency syndrome
  • anti-HBe antibody to hepatitis B e antigen
  • anti-HBc antibody to hepatitis B core antigen
  • anti-HBs antibody to hepatitis B surface antigen
  • AOM acute otitis media
  • ASCIA Australasian Society of Clinical Immunology and Allergy
  • ATAGI Australian Technical Advisory Group on Immunisation
  • BCG bacille Calmette-Guérin
  • CCID50 cell culture infectious dose 50%
  • CDNA Communicable Diseases Network Australia
  • CI confidence interval
  • CIN cervical intraepithelial neoplasia
  • CRS congenital rubella syndrome
  • CSF cerebrospinal fluid
  • DNA deoxyribonucleic acid
  • DT diphtheria-tetanus vaccine for use in children (for further explanation of this term, see Appendix 5 Glossary of technical terms)
  • dT diphtheria-tetanus vaccine for use in adults (for further explanation of this term, see Appendix 5 Glossary of technical terms)
  • DTPa diphtheria-tetanus-acellular pertussis vaccine (for further explanation of this term, see Appendix 5 Glossary of technical terms)
  • dTpa diphtheria-tetanus-acellular pertussis vaccine, reduced antigen content formulation (for further explanation of this term, see Appendix 5 Glossary of technical terms)
  • DTPw diphtheria-tetanus-whole-cell pertussis vaccine (for further explanation of this term, see Appendix 5 Glossary of technical terms)
  • EIA enzyme immunoassay
  • ELISA enzyme-linked immunosorbent assay
  • FHA filamentous haemagglutinin
  • FIM fimbriae (pertussis)
  • GBS Guillain-Barré syndrome
  • GP general practitioner
  • GVHD graft-versus-host disease
  • HAV hepatitis A virus
  • HBcAg hepatitis B core antigen
  • HBeAg hepatitis B e antigen
  • HBIG hepatitis B immunoglobulin
  • HBsAg hepatitis B surface antigen
  • HBV hepatitis B virus
  • HCW healthcare worker
  • HDCV human diploid cell vaccine (rabies)
  • HepA hepatitis A vaccine
  • HepB hepatitis B vaccine
  • HHE hypotonic-hyporesponsive episode
  • Hib Haemophilus influenzae type b
  • Hib-MenCCV Haemophilus influenzae type b-meningococcal C conjugate vaccine
  • HIV human immunodeficiency virus
  • HPV human papillomavirus
  • 2vHPV bivalent HPV vaccine
  • 4vHPV quadrivalent HPV vaccine
  • HRIG human rabies immunoglobulin
  • HSCT haematopoietic stem cell transplant
  • HZ herpes zoster
  • ID intradermal
  • IgA/G/M immunoglobulin A/G/M
  • IM intramuscular
  • IPD invasive pneumococcal disease
  • IPV inactivated poliomyelitis vaccine
  • IS intussusception
  • ITP idiopathic thrombocytopenia purpura
  • IU international units
  • IV intravenous
  • JE Japanese encephalitis
  • LT-ETECheat- labile toxin producing enterotoxigenic Escherichia coli
  • MenCCV meningococcal serogroup C conjugate vaccine
  • 4vMenCV quadrivalent meningococcal conjugate vaccine
  • 4vMenPV quadrivalent meningococcal polysaccharide vaccine
  • MMR measles-mumps-rubella
  • MMRV measles-mumps-rubella-varicella
  • NCIRS National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases
  • NHIG normal human immunoglobulin
  • NHMRC National Health and Medical Research Council
  • NHVPR National HPV Vaccination Program Register
  • NIP National Immunisation Program
  • NSW New South Wales
  • NT Northern Territory
  • NTHi non-typeable Haemophilus influenzae
  • OMP outer membrane protein
  • OPV oral poliomyelitis vaccine
  • PCECV purified chick embryo cell vaccine (rabies)
  • PCR polymerase chain reaction
  • 7vPCV 7-valent pneumococcal conjugate vaccine
  • 10vPCV 10-valent pneumococcal conjugate vaccine
  • 13vPCV 13-valent pneumococcal conjugate vaccine
  • PEP post-exposure prophylaxis
  • pH1N1 pandemic influenza A(H1N1)pdm09
  • PHN post-herpetic neuralgia
  • PI product information
  • PreP pre-exposure prophylaxis
  • 23vPPV 23-valent pneumococcal polysaccharide vaccine
  • PRN pertactin
  • PRP polyribosylribitol phosphate
  • PRP-OMP PRP conjugated to the outer membrane protein of Neisseria meningitidis
  • PRP-T PRP conjugated to tetanus toxoid
  • PT pertussis toxoid
  • Qld Queensland
  • RCT randomised controlled trial
  • RIG rabies immunoglobulin
  • RNA ribonucleic acid
  • SA South Australia
  • SC subcutaneous
  • SCID severe combined immunodeficiency
  • SIDS sudden infant death syndrome
  • SOT solid organ transplant
  • SSPE subacute sclerosing panencephalitis
  • Tas Tasmania
  • TB tuberculosis
  • TCID50 tissue culture infectious dose 50%
  • TGA Therapeutic Goods Administration
  • TIG tetanus immunoglobulin
  • TST tuberculin skin test
  • Vic Victoria
  • VLP virus-like particle
  • VNAb (rabies) virus neutralising antibody
  • VPD vaccine-preventable disease
  • VV varicella vaccine
  • VZV varicella-zoster virus
  • WA Western Australia
  • WHO World Health Organization
  • ZIG zoster immunoglobulin